Basse Anna Modji*, Mpung H, Sow AD, Diagne NS, Diop MS, Gaye A, Seck LB, Toure K, Ndiaye M and Diop AG

Department of Neurology, Fann teaching hospital, Dakar, Senegal

*Corresponding Author: Basse Anna Modji, Department of Neurology, Fann teaching hospital, Dakar, Senegal.

Received: September 06, 2023; Published:November 27, 2023

Abstract

Lung cancer is the second most common malignant disease worldwide. It is estimated that around 2.2 million new cases of lung cancer are diagnosed each year. The clinic is very polymorphous, the neurological manifestation can be part of a paraneoplastic syndrome or secondary damage by tumor infiltration. The damage can be central or be central or peripheral. Here we report a case of a known smoking patient who presented with peripheral neurogenic syndrome which revealed lung cancer.

Keywords: Sensitive Neuropathy; Lung Cancer

References

1. Global Burden of Disease Cancer Collaboration, Fitzmaurice C., et al. “Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017: A Systematic Analysis for the Global Burden of Disease Study”. JAMA Oncology12 (2019): 1749‑1768.
2. Graus F., et al. “Recommended diagnostic criteria for paraneoplastic neurological syndromes”. Journal of Neurology, Neurosurgery, and Psychiatry8 (2004): 1135‑1140.
3. Honnorat J and Antoine J-C. “Paraneoplastic neurological syndromes”. Orphanet Journal of Rare Diseases 1 (2007): 1‑8.
4. Giovannini S., et al. “Neuropathic pain in the elderly”. Diagnoses4 (2021): 613.
5. Antoine JC., et al. “Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti- onconeural antibodies”. Journal of Neurology, Neurosurgery, and Psychiatry 1 (1999): 7‑14.
6. Kanaji N., et al. “Paraneoplastic syndromes associated with lung cancer”. World Journal of Clinical Oncology 3 (2014): 197.
7. Graus: Recommended diagnostic criteria for paraneoplastic.
8. Chalk CH., et al. “The distinctive clinical features of paraneoplastic sensory neuronopathy”. Canadian Journal of Neurological Sciences3 (1992): 346-351.
9. De Beukelaar JW and Smitt NOT. “Managing paraneoplastic neurological disorders”. The Oncologist3 (2006): 292‑305.
10. Sillevis Smitt P., et al. “Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis / sensory neuronopathy”. Journal of Neurology 249 (2002): 745‑7
11. Ramchandren: Metastases to the peripheral nervous system.
12. Azzarelli: Leukemic cell-endothelial cell interactions.
13. Foley KM., et al. “Radiation- induced malignant and atypical peripheral nerve sheath tumours”. Annals of Neurology 4 (1980): 311‑318.
14. Bhattacharyya AK., et al. “Peripheral nerve tumors : management strategies and molecular insights”. Journal of Neurooncology 69 (2004): 335‑3
15. Enting HR. “Leptomeningeal neoplasia : epidemiology, clinical presentation, CSF analysis and diagnostic imaging”. Leptomeningeal Metastases (2005): 17‑
16. C Chamberlain M., et al. “Leukemic and lymphomatous meningitis: incidence, prognosis and treatment”. Journal of Neurooncology 75 (2005): 71‑
17. Lister A., et al. “Central nervous system lymphoma”. ASH Education Program Book 1 (2002): 283‑2
18. Kaplan JG., et al. “Leptomeningeal metastases : comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias”. Journal of Neurooncology 9 (1990): 225‑22
19. Chamberlain MC., et al. “Leptomeningeal metastasis : A comparison of gadolinium- enhanced MR and contrast-enhanced CT of the brain”. Neurology3 (1990): 435‑435.
20. Glantz MJ., et al. “Cerebrospinal fluid cytology in patients with cancer: minimizing false‐ negative results”. Interdisciplinary International Journal of the American Cancer Society 4 (1998): 733‑739.
21. van Oostenbrugge RJ., et al. “Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization”. Journal of Neuropathology and Experimental Neurology6 (1997): 743‑748.
22. Cheng TM., et al. “Chronic meningitis: the role of meningeal or cortical biopsy”. Neurosurgery 4 (1994): 590‑596.
23. Kori SH., et al. “Brachial plexus lesions in patients with cancer= 100 cases”. Neurology 1 (1981): 45‑45.
24. Jaeckle KA. “Nerve plexus metastases”. Neurology Clinics4 (1991): 857-866.

Citation

Citation: Basse Anna Modji., et al. “Subacute Sensitive Neuropathy Revealing Lung Cancer About of a Case". Acta Scientific Clinical Case Reports 4.12 (2023): 49-52.

Copyright

Copyright: © 2023 Basse Anna Modji., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.